Department of Chemistry and Biochemistry, Queens College and the Graduate Center of The City University of New York, Queens, NY 11367-1597, USA.
Bioorg Med Chem. 2013 Jun 1;21(11):2975-87. doi: 10.1016/j.bmc.2013.03.062. Epub 2013 Apr 2.
Cysteine cathepsins are an important class of enzymes that coordinate a variety of important cellular processes, and are implicated in various types of human diseases. However, small molecule inhibitors that are cell-permeable and non-peptidyl in nature are scarcely available. Herein the synthesis and development of sulfonyloxiranes as covalent inhibitors of cysteine cathepsins are reported. From a library of compounds, compound 5 is identified as a selective inhibitor of cysteine cathepsins. Live cell imaging and immunocytochemistry of metastatic human breast carcinoma MDA-MB-231 cells document the efficacy of compound 5 in inhibiting cysteine cathepsin activity in living cells. A cell-motility assay demonstrates that compound 5 is effective in mitigating the cell-migratory potential of highly metastatic breast carcinoma MDA-MB-231 cells.
半胱氨酸组织蛋白酶是一类重要的酶,它们协调多种重要的细胞过程,并与各种类型的人类疾病有关。然而,具有细胞通透性和非肽性质的小分子抑制剂却很少见。本文报道了磺酰氧杂环丁烷作为半胱氨酸组织蛋白酶的共价抑制剂的合成和发展。从化合物文库中,鉴定出化合物 5 是半胱氨酸组织蛋白酶的选择性抑制剂。活细胞成像和转移性人乳腺癌 MDA-MB-231 细胞的免疫细胞化学显示,化合物 5 能够有效地抑制活细胞中的半胱氨酸组织蛋白酶活性。细胞迁移实验表明,化合物 5 能有效抑制高转移性乳腺癌 MDA-MB-231 细胞的迁移能力。